Pressroom

Pressroom

Gestalt in the Press &
Out in the Industry

Press Releases


Gestalt logo
By Lisa-Jean Clifford 26 Apr, 2024
Gestalt’s Advisory Board guides the development of Gestalt’s digital pathology platform, PathFlow® – made by pathologists for pathologists
Gestalt Logo
By Lisa-Jean Clifford 22 Mar, 2024
Gestalt Diagnostics, Inc., a leading provider of (AI)-driven digital pathology solutions, is proud to announce the launch of its leading-edge AI Algorithm Evaluator. This groundbreaking, patent-pending tool empowers pathologists, researchers, and healthcare professionals to assess and compare the performance of AI algorithms with unprecedented precision directly within our award-winning PathFlow® solution. This new feature will be demonstrated during the USCAP 2024 conference in Baltimore this week.
By Lisa-Jean Clifford 20 Mar, 2024
March 20, 2024 – Spokane, Washington – Gestalt, a leading provider of (AI)-driven digital pathology solutions, is excited to announce a series of significant enhancements to its educational module and digital pathology solution, within the PathFlow® solution. These advancements underscore Gestalt's commitment to transforming healthcare from every perspective. Our newly expanded Education Module now includes automated, digital evaluation, proficiency testing, credentialing management, and results comparison features. Designed to streamline and ease the heavily manual processes of pathologist proficiency testing, onboarding, and credentialing. "Our commitment to innovation extends across all facets of pathology, from Anatomic Pathology (AP), Research, and Education to Management and Administrative functions. These enhancements reflect our vision for a future where education and technology converge to improve operational processes," says Lisa-Jean Clifford, Chief Strategy Officer and COO at Gestalt Diagnostics. "Our solutions are designed to significantly streamline workflow, enhance efficiency, support patient safety, and offer improved quality and cost. We believe that delivering products with these goals in mind will have a major impact on operations within healthcare, academic, and research facilities, for the pathologist, scientist, and clinician, ultimately providing faster, more accurate diagnosis and treatment for the patient and optimized operations with significant savings to organizations." Gestalt Diagnostics has a proven track record of excellence. Its customers are already leveraging the company's expertise for primary diagnoses*, tumor boards, onboarding and training, collaboration, and supporting remote access for hundreds of client pathologists who are geographically dispersed. Additionally, Gestalt supports research and retrospective image and data capture for over 10 million pathology slides. Join us at USCAP, March 23-28, at booth #554 to see how our efforts in clinical, education, and research initiatives are setting new standards in digital solutions. *Research use only unless following CAP guidelines for LDT. CE-IVD certified for use in Europe.
Show More

Publications


G2 Intelligence logo
By Lisa-Jean Clifford 03 Feb, 2024
Featured in G2 Intelligence January 2024—In an insightful discussion on the evolving landscape of data analytics within clinical laboratories, Lisa-Jean Clifford, COO and Chief Strategy Officer at Gestalt Diagnostics, highlights the integration of data analytics across various facets of laboratory operations. She emphasizes its critical role in enhancing operational efficiency, resource management, and patient safety. Clifford's commentary sheds light on the extensive applications of data analytics in lab environments—from streamlining operational workflows to improving patient care. She also addresses the challenges labs face, such as navigating the vast array of data analytics solutions and the need for specialized knowledge in pathology informatics. Moreover, Clifford points to the promising future of digital solutions and AI in expanding the capabilities of clinical labs, suggesting a burgeoning potential for growth and innovation in the field.
By Lisa-Jean Clifford 20 Dec, 2023
Featured in CAP TODAY December 2023—Digital pathology and AI—the push, the potential, the changing questions, the reimbursement, and the caution. All that and more came up when CAP TODAY publisher Bob McGonnagle led a conversation online with pathologists and industry representatives, featuring Lisa-Jean Clifford, COO and Chief Strategy Officer of Gestalt.
pathologist using microscope in lab
By Lisa-Jean Clifford 09 Nov, 2023
With the advancement and expanded uses of technology in the laboratory we have a host of opportunities in the hands of physicians and scientists to explore and study diseases in-depth and in a way that we historically have not been able to. Read on to discover more...
Show More

Blog


Digital Pathology Today Logo
By Lisa-Jean Clifford 23 Apr, 2024
A Digital Pathology Today podcast with Lisa-Jean Clifford of Gestalt - A Fresh Start for Pathology
Gestalt logo
By Valerie Collinsworth 21 Dec, 2022
Lisa-Jean Clifford’s Affective Dedication to Advance Pathology Informatics Through Service in Key Influential Non-Profit Organizations is Commendable
digital pathology today
By Andrew Hite 28 Apr, 2021
This episode's guests: Felix Faber and Lisa-Jean Clifford
Show More

DIGIPATH Dispatch Quarterly Newsletter


By Lisa-Jean Clifford 26 Jan, 2024
By Lisa-Jean Clifford 05 Oct, 2023
Gestalt July 2023 Company Newsletter
By Lisa-Jean Clifford 25 Jul, 2023
The integration of digital pathology and AI is revolutionizing laboratory practices, promising a future where diagnostic precision and patient care reach unprecedented heights.
Show More

Frequently Asked Questions


Digital Pathology Workflow
By Lisa-Jean Clifford 21 Nov, 2022
Short answers to frequently asked questions about digital pathology.
Show More
Share by: